NeuroOne Medical Technologies Corporation
NMTCNASDAQHealthcareMedical - Devices
Previous close
$2.03
−$0.12 · -5.58%
Pre-market
$1.9105
−$0.1195 · -5.89%
Aug 24, 8:56 AM ET
NMTC company overview
Historical prices · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
69
Undervalued
Momentum
22
Weakening
Sentiment
30
Bearish
Risk resilience
36
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteNeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- David A. Rosa
- Listed since
- Mar 15, 2018
- Employees
- 18
Market position
Day range
Current $2.03
52-week range
Current $2.03
- Open
- $1.985
- Previous close
- $2.15
- Volume
- 35.34K
- 0.72× average
- Average volume
- 49.38K
- Average daily volume
- Market cap
- 17.67M USD
- Beta
- 0.64
- Market reference 1
- 50-day average
- $2.4125
- -15.85% below average
- 200-day average
- $3.9494
- -48.60% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 29.37M USD
- P/E (TTM)
- -2.22×
- P/B (TTM)
- 4.67×
- P/S (TTM)
- 1.77×
- EV / EBITDA
- -9.76×
- Earnings yield
- -10.11%
- Free cash flow yield
- -8.18%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 55.67%
- Operating margin
- -76.05%
- Net margin
- -71.51%
- Return on equity
- -50.98%
- Return on assets
- -33.43%
- Return on invested capital
- -49.11%
Financial health
- Debt / equity
- 0.02×
- Current ratio
- 4.44×
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- -33.89%
- 11 comparable reports
- Latest EPS result
- -0.28
- Estimate -0.21 · Miss by 33.33%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
NMTC news
NMTC peers
ETFs holding NMTC
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 430.85K
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 152.3K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 51.5K
- Weight
- 0.00%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Continue in GoAI
Research NMTCresearch.disclaimer